Skip to content

Théfapépsy

Active
Private limited companyfounded 2002active for 24 yearsAvenue de la Bourse 1, 1300 Wavre, BelgiumKBO/BCE: BE 0476.692.741
Summary

Théfapépsy has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36,628 and a net result of €11,423. Equity is growing by about 48% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
ThéfapépsyActiveChecked score 94/100
Risk analysis ReportCompare

History

On 17 January 2002, Théfapépsy was incorporated.1 In 2023 the company took the name Théfapépsy.2 GOAREGUER Frédéric has served as director of the company since 2023.2 Total assets went from €6,791 in 2018 to €39,474 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 20-10-2023
  3. 3National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
25-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Highest result from 2018 to 2025net €11,423 ▲345%
Net result €11,423, the highest in the series.
20-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Liquidity more than 9 timescurrent ratio 37.07
Current ratio from 4.02 to 37.07; short-term debt falls from €6,935 to €669.
26-09
Gazette deed Amendment of the articles
Correction3 facts ▸
  • General meeting, 18-09-2024
  • Correction, “erreur matérielle”, 23 (deed in French)
  • Amendment of the articles, 23
28-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Liquidity more than triplescurrent ratio 4.02
Current ratio from 1.28 to 4.02; short-term debt falls from €12,018 to €6,935.
20-10
Gazette deed Resignation: GOAREGUER Frédéric (manager)
Appointment: GOAREGUER Frédéric (director) · Director discharge · Name change10 facts ▸
  • General meeting, 11-10-2023
  • Director resignation, GOAREGUER Frédéric (manager)
  • Director discharge, GOAREGUER Frédéric (manager)
  • Director appointment, GOAREGUER Frédéric (director (not named in the articles))
  • Name change, Théfapépsy
  • Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
  • Reserve release, “suppression du compte de capitaux propres statutairement indisponible, fonds disponibles pour distribution” (deed in French)
  • Amendment of the articles (2 times)
  • Other provision, “distinction sociétés civiles/sociétés commerciales supprimée par le Code des sociétés et des associations, société civile étant une société privée à responsabil…” (deed in French)
  • Capital
12-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
26-08
NBB filing Annual accounts filed
financial year 2021 · micro format · 26 days late
2021
15-07
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
03-08
NBB filing Annual accounts filed
financial year 2019 · micro format · 3 days late
Show earlier events
2019
31-12
Financial Back to profitnet €10,790
Net result €10,790 after one loss-making year.
02-08
NBB filing Annual accounts filed
financial year 2018 · micro format · 2 days late
2018
07-08
NBB filing Annual accounts filed
financial year 2017 · micro format · 7 days late
2017
30-09
NBB filing Annual accounts filed
financial year 2016 · micro format · 61 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 24 annual accounts filed, the latest 10 are here; all 24 are under Financials.
2 of 2 deeds read

We would like to set cookies. That happens only with your consent. What we measure